Michael P Pender Selected Research

Myelin Proteolipid Protein

1/2020	Correlation Between Anti-Myelin Proteolipid Protein (PLP) Antibodies and Disease Severity in Multiple Sclerosis Patients With PLP Response-Permissive HLA Types.
1/2017	Reactivity to Novel Autoantigens in Patients with Coexisting Central Nervous System Demyelinating Disease and Autoimmune Thyroid Disease.
11/2008	Myelin proteolipid protein: an effective autoantigen and target of autoimmunity in multiple sclerosis.
3/2005	Blood-brain barrier disruption and lesion localisation in experimental autoimmune encephalomyelitis with predominant cerebellar and brainstem involvement.
6/2004	Effect of gender on T-cell proliferative responses to myelin proteolipid protein antigens in patients with multiple sclerosis and controls.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael P Pender Research Topics

Disease

21	Multiple Sclerosis 04/2021 - 03/2004
4	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 11/2003
4	Epstein-Barr Virus Infections 10/2014 - 06/2009
4	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/2008 - 09/2004
3	Demyelinating Diseases (Demyelinating Disease) 01/2017 - 09/2004
3	Schizophrenia (Dementia Praecox) 04/2014 - 02/2005
3	Inflammation (Inflammations) 10/2012 - 07/2004
3	Disease Progression 10/2012 - 09/2004
2	Central Nervous System Diseases (CNS Diseases) 01/2017 - 11/2008
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2020
1	Fatigue 11/2018
1	Thyroid Diseases (Thyroid Disease) 01/2017
1	Vitamin D Deficiency 05/2013
1	Tertiary Lymphoid Structures 01/2012
1	Seasonal Allergic Rhinitis (Hay Fever) 05/2011
1	Asthma (Bronchial Asthma) 05/2011
1	Hypersensitivity (Allergy) 05/2011
1	Sunburn 11/2009
1	Nervous System Diseases (Neurological Disorders) 05/2008
1	Glioma (Gliomas) 06/2006
1	Glioblastoma (Glioblastoma Multiforme) 06/2006
1	Vascular Diseases (Vascular Disease) 04/2006
1	Neuroinflammatory Diseases 04/2006
1	Peripheral Nervous System Diseases (PNS Diseases) 05/2005
1	Guillain-Barre Syndrome 05/2005
1	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 05/2005
1	Infections 11/2003
1	Genetic Predisposition to Disease (Genetic Predisposition) 11/2003
1	Chronic Progressive Multiple Sclerosis 01/2003

Drug/Important Bio-Agent (IBA)

6	AutoantibodiesIBA 10/2014 - 02/2005
5	Myelin Proteolipid ProteinIBA 01/2020 - 06/2004
4	AntigensIBA 10/2014 - 11/2003
4	Vitamin D FDA LinkGeneric 05/2013 - 05/2011
3	AntibodiesIBA 01/2020 - 09/2004
2	Proteins (Proteins, Gene)FDA Link 08/2020 - 05/2008
2	AutoantigensIBA 01/2017 - 11/2008
2	RNA (Ribonucleic Acid)IBA 10/2014 - 12/2011
2	Antiviral Agents (Antivirals)IBA 10/2014 - 06/2009
2	Neurotransmitter Receptors (Neurotransmitter Receptor)IBA 04/2014 - 02/2005
2	3' Untranslated Regions (3' UTR)IBA 05/2009 - 03/2009
2	Neurotransmitter Agents (Neurotransmitter)IBA 04/2006 - 02/2005
2	GangliosidesIBA 05/2005 - 01/2003
1	Immunoglobulin G (IgG)IBA 11/2018
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2017
1	Calcitonin Gene-Related PeptideIBA 01/2017
1	Leucine (L-Leucine)FDA Link 01/2017
1	Thyrotropin Receptors (Thyrotropin Receptor)IBA 01/2017
1	Crystallins (Crystallin)IBA 10/2014
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 04/2014
1	N 30IBA 04/2014
1	Interleukin-6 (Interleukin 6)IBA 10/2012
1	Cod Liver OilIBA 05/2011
1	Toll-Like Receptor 3IBA 05/2010
1	SiliconesIBA 11/2009
1	Leukemia Inhibitory FactorIBA 05/2009
1	Leukocyte Common Antigens (CD45 Antigen)IBA 02/2009
1	Myelin ProteinsIBA 05/2008
1	Estrogen ReceptorsIBA 01/2007
1	Glial Fibrillary Acidic ProteinIBA 06/2006
1	catechol (pyrocatechol)IBA 04/2006
1	HomocysteineIBA 04/2006
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 04/2006
1	EnzymesIBA 04/2006
1	CatecholaminesIBA 04/2006
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 04/2006
1	TransferasesIBA 04/2006
1	G(M1) GangliosideIBA 05/2005
1	Peptides (Polypeptides)IBA 03/2005
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2005
1	Chemokine ReceptorsIBA 09/2004
1	ChemokinesIBA 09/2004
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 07/2004
1	Biological ProductsIBA 07/2004
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2004
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 03/2004
1	CytokinesIBA 11/2003
1	G(M3) GangliosideIBA 01/2003

Therapy/Procedure

5	Immunotherapy 04/2021 - 06/2006
3	Therapeutics 01/2021 - 11/2018